# R-FACT Study:Risk Factors for Alloimmunization After Red Blood Cell Transfusions

> **NCT01616329** · — · COMPLETED · sponsor: **Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research** · enrollment: 1500 (actual)

## Conditions studied

- Hemolysis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01616329
- **Lead sponsor:** Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2017-08
- **Final completion:** 2017-12
- **Target enrollment:** 1500 (ACTUAL)
- **Last updated:** 2022-05-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01616329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01616329, "R-FACT Study:Risk Factors for Alloimmunization After Red Blood Cell Transfusions". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01616329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*